Enavermotide

CAT: 0804-HY-P5534Size: 1 EachDry Ice: NoHazardous: No

1 / 1

CAT#:0804-HY-P5534Size:1 Each

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Description

Enavermotide (UCP2) is an immunological agent for active immunization (antineoplastic) [1].

CAS Number

524060-93-3

Product Name Alternative

UCP2

UNSPSC

12352209

Target

Others

Type

Peptides

Related Pathways

Others

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/enavermotide.html

Solubility

10 mM in DMSO

Smiles

O=C(N[C@@H](CO)C(N[C@@H](CCCCN)C(N[C@@H](CC(C)C)C(N[C@@H](CCC(N)=O)C(N[C@@H](CO)C(N[C@@H]([C@@H](C)CC)C(NCC(N[C@@H]([C@@H](C)CC)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCC(N)=O)C(N[C@H](C(O)=O)CC1=CN=CN1)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@@H](NC([C@H](C(C)C)NC([C@H](CO)NC([C@@H](N)CCCCN)=O)=O)=O)CC2=CNC3=CC=CC=C23

Molecular Formula

C79H131N25O21

Molecular Weight

1767.04

References & Citations

[1]Godet Y, et al. Analysis of spontaneous tumor-specific CD4 T-cell immunity in lung cancer using promiscuous HLA-DR telomerase-derived epitopes: potential synergistic effect with chemotherapy response. Clin Cancer Res. 2012 May 15;18 (10) :2943-53.

Shipping Conditions

Room temperature

Scientific Category

Peptides

Clinical Information

No Development Reported

Alternative Products

Catalog	Name
T82473-01	Enavermotide

Enavermotide

Alternative Products

Popular Products